HRSA Updates Cervical Cancer Screening Guidelines to Include Self-Collection
New guidelines designate high-risk HPV testing as preferred screening method for women ages 30-65 and require insurance coverage for additional testing.
New guidelines designate high-risk HPV testing as preferred screening method for women ages 30-65 and require insurance coverage for additional testing.
Liquid biopsy is proving itself as both an efficacious and cost-effective way to provide a cancer diagnosis to patients.
In spite of USPSTF recommendations, ACOG reaffirms its previous guidance in favor of cotesting with cytology and high-risk HPV testing for women aged 30–65 years.